UK's first project for medical cannabis launches - EPM Magazine The UK’s first national medical cannabis project has been launched with a goal of recruiting 20,000 patients before the end of 2021. Launched by Drug Science’s Medical Cannabis Working Group, Project TWENTY21 will focus on a range of patients and situations where alternative treatments have failed. These include patients with chronic pain, PTSD with a focus on the veteran community, multiple sclerosis and Tourette’s. More so the project will place a particular focus on prison populations who are susceptible to harm and substance use disorder as a harm reduction strategy. The project will develop a body of evidence using a real-world data registry which documents the efficacy, safety, QALY (quality, adjusted, life, year) and patient reported outcomes in those prescribed medical cannabis. The data will be used to assist health authorities to assess patient applications in the hope that there will soon be a new